Key result
The author expresses reservations about the usefulness of trial registries for individual practitioners in addressing publication bias, suggesting medical journals should take their own steps.
Answers are grounded in this paper and cite their sources.
Discusses the role of investigators and medical journals in addressing publication bias.
To the Editor. —The recent Editorial by Dr Rennie and Ms Flanagin 1 summarized the state of our knowledge on publication bias, its determinants, and the logical possible steps to counteract its existence. While I have no doubts that the implementation of remedial actions (such as prospective registration of trials conditional on funding 2 and careful monitoring by institutional review boards, etc) will be very useful for investigators and meta-analysts, I have reservations on the usefulness of registries of trials for individual practitioners who are most of the time not well educated on critical appraisal of the medical literature, to say nothing about publication bias. Even though Rennie and Flanagin are correct when, in looking at the findings by Dickersin et al 3 and others, 4 they point out that most publication bias is due to the investigators themselves, I believe that medical journals should take their own steps against
No takes yet. Share an insight, caveat, or question.
Alessandro Liberati (1992) conducted a letter in Publication bias. The author expresses reservations about the usefulness of trial registries for individual practitioners in addressing publication bias, suggesting medical journals should take their own steps.
Synapse has enriched 10 related papers. Consider them for comparative context: